Search Results - "Gil, Amalia Pérez"

Super responders to guselkumab treatment in moderate‐to‐severe psoriasis: a real clinical practice pilot series by Ruiz‐Villaverde, Ricardo, Rodriguez‐Fernandez‐Freire, Lourdes, Armario‐Hita, Jose C., Pérez‐Gil, Amalia, Galán‐Gutiérrez, Manuel

“…Background The term super responders defines a subset of patients with moderate‐to‐severe psoriasis that present a rapid and higher rate of response to…”
Get full text

Guselkumab as a switching strategy after anti‐TNFα, anti‐IL17, or anti‐IL12/23 therapies in moderate‐to‐severe psoriasis by Ruiz‐Villaverde, Ricardo, Rodriguez‐Fernandez‐Freire, Lourdes, Armario‐Hita, Jose Carlos, Pérez‐Gil, Amalia, Chinchay, Fiorella Vasquez, Galán‐Gutiérrez, Manuel

“…The IL23/Th17 axis plays a strategic role in psoriasis (PSO). Guselkumab (GUS) is a selective inhibitor of the IL23p19 subunit. Its introduction has managed to…”
Get full text

Worsening of high‐grade squamous intraepithelial lesion (HSIL) with pubic hair removal by García‐Souto, Fernando, Pérez‐Gil, Amalia, Peña‐Sánchez, Roberto, Escudero‐Ordoñez, Jerónimo

Get full text

Guselkumab dosing interval optimization in adult patients with moderate‐to‐severe psoriasis switching from ustekinumab by Ruiz‐Villaverde, Ricardo, Chinchay, Fiorella Vasquez, Rodriguez‐Fernandez‐Freire, Lourdes, Armario‐Hita, Jose C., Pérez‐Gil, Amalia, Galán‐Gutiérrez, Manuel

“…Psoriasis (PSO) is an inflammatory disease that emerges as a dysregulation of the interleukin 23 (IL23)/Th17 axis. There are many biologic alternatives to…”
Get full text

Brentuximab vedotin in the treatment of cutaneous T‐cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry by Muniesa, Cristina, Gallardo, Fernando, García‐Doval, Ignacio, Estrach, M. Teresa, Combalia, Andrea, Morillo‐Andújar, Mercedes, De la Cruz‐Vicente, Fátima, Machan, Salma, Moya‐Martínez, Cristina, Rovira, Roger, Sanchez‐Gonzalez, Blanca, Acebo, Elvira, Amutio, Elena, Peñate, Yeray, Losada‐Castillo, Maria del Carmen, García‐Muret, M. Pilar, Iznardo, Helena, Román‐Curto, Concepción, Cañueto, Javier, Fernández‐de‐Misa, Ricardo, Flórez, Ángeles, Izu, Rosa María, Torres‐Navarro, Ignacio, Zayas, Ana, Pérez‐Paredes, Gema, Blanes, Mar, Yanguas, J. Ignacio, Pérez‐Ferriols, Amparo, Callejas‐Charavia, Marta, Ortiz‐Romero, Pablo Luis, Pérez‐Gil, Amalia, Prieto‐Torres, Lucia, González‐Barca, Eva, Servitje, Octavio

“…ABSTRCT Background Brentuximab vedotin (BV) has been approved for CD30‐expressing cutaneous T‐cell lymphoma (CTCL) after at least one previous systemic…”
Get full text

Super-Responders in Moderate–Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives by Ruiz-Villaverde, Ricardo, Vasquez-Chinchay, Fiorella, Rodriguez-Fernandez-Freire, Lourdes, C. Armario-Hita, Jose, Pérez-Gil, Amalia, Galán-Gutiérrez, Manuel

“…A fast skin clearance is the main goal to achieve in psoriasis treatment. Patients that present a fast and exceptional improvement with treatment are called…”
Get full text

Squamous cell carcinoma of the penis successfully treated with imiquimod 5% cream in a porphyria cutanea tarda patient by Fernández‐Crehuet, Pablo, Ruiz‐Villaverde, Ricardo, Rios‐Martin, Juan J, Pérez‐Gil, Amalia, Camacho‐Martinez, Francisco

Get full text

Effective management of acrodermatitis continua of Hallopeau with guselkumab in a Wiskott-Aldrich syndrome patient by Morón-Ocaña, Juan-Manuel, Pérez-Gil, Amalia

Get full text

Guselkumab: Mid‐term effectiveness, drug survival, and safety in real clinical practice by Ruiz‐Villaverde, Ricardo, Rodriguez‐Fernandez‐Freire, Lourdes, Armario‐Hita, Jose Carlos, Pérez‐Gil, Amalia, Galán‐Gutiérrez, Manuel

“…Guselkumab is a fully human immunoglobulin‐G1‐lambda (IgG1λ) monoclonal antibody that binds selectively to the p19 subunit of interleukin 23. Few series of…”
Get full text

Association between sleep disordered breathing and aggressiveness markers of malignant cutaneous melanoma by MARTINEZ-GARCIA, Miguel-Angel, MARTORELL-CALATAYUD, Antonio, CAMPOS-RODRIGUEZ, Francisco, FARRE, Ramón, NAGORE, Eduardo, VALERO, Irene, SELMA, Maria Jose, CHINER, Eusebi, LANDETE, Pedro, MONTSERRAT, Josep-Maria, CARRERA, Cristina, PEREZ-GIL, Amalia

“…Some recent studies have shown an association between sleep disordered breathing (SDB) and cancer mortality and incidence but no study has focused on a…”
Get full text

Erdheim-Chester disease BRAF (-) Diagnosis through cutaneous manifestations and good response with anakinra treatment by Morón-Ocaña, Juan-Manuel, Pérez-Gil, Amalia

Get full text

Risankizumab: Efficacy, Safety, and Survival in the Mid-Term (52 Weeks) in Real Clinical Practice in Andalusia, Spain, According to the Therapeutic Goals of the Spanish Psoriatic Guidelines by Ruiz-Villaverde, Ricardo, Rodriguez-Fernandez-Freire, Lourdes, Pérez-Gil, Amalia, Font-Ugalde, Pilar, Galán-Gutiérrez, Manuel

“…Introduction. Risankizumab is a humanized monoclonal antibody of the immunoglobulin G1 (IgG1) type that binds selectively, and with high affinity, to the p19…”
Get full text

Effectiveness, survival and safety of guselkumab attending to basal characteristics in moderate-to-severe psoriatic patients: a cohort study [version 1; peer review: 1 approved with reservations] by Ruiz-Villaverde, Ricardo, Rodriguez-Fernandez-Freire, Lourdes, Armario-Hita, Jose C., Pérez-Gil, Amalia, Vasquez Chinchay, Fiorella, Galán-Gutiérrez, Manuel

“…Background: Psoriasis is a chronic inflammatory disease which can impact quality of life. In the past decade multiple biologic treatments have been released…”
Get full text

Interstitial granulomatous dermatitis due to a rare myeloproliferative neoplasia by Cases-Merida, Sandra, Lorente-Lavirgen, Ana, Pérez-Gil, Amalia

“…Interstitial granulomatous dermatitis (IGD) was first described in 1993 by Ackerman as a cutaneous reactive disease in patients with arthritis. Since then,…”
Get full text

Guselkumab: Short‐term effectiveness and safety in real clinical practice by Rodriguez Fernandez‐Freire, Lourdes, Galán‐Gutierrez, Manuel, Armario‐Hita, Jose Carlos, Perez‐Gil, Amalia, Ruiz‐Villaverde, Ricardo

Get full text

Visual Dermatology: Wolf’s Isotopic Response: Zosteriform Psoriasis by Garcia-Souto, Fernando, Martínez-Barranca, Maria Luisa, Pérez-Gil, Amalia, Escudero-Ordoñez, Jerónimo

Get full text

A prospective multicenter cohort study of cutaneous melanoma: clinical staging and potential associations with HIF-1α and VEGF expressions by Martínez-García, Miguel Ángel, Riveiro-Falkenbach, Erica, Rodríguez-Peralto, José L, Nagore, Eduardo, Martorell-Calatayud, Antonio, Campos-Rodríguez, Francisco, Farré, Ramón, Hernández Blasco, Luis, Bañuls Roca, Jose, Chiner Vives, Eusebi, Sánchez-de-la-Torre, Alicia, Abad Capa, Jorge, Montserrat, Josep Maria, Almendros, Isaac, Pérez-Gil, Amalia, Cabriada Nuño, Valentin, Cano-Pumarega, Irene, Corral Peñafiel, Jaime, Diaz Cambriles, Trinidad, Mediano, Olga, Dalmau Arias, Joan, Gozal, David

“…Melanoma is a highly prevalent cancer that is associated with substantial mortality. Although clinical staging procedures can serve as relatively robust…”
Get full text

Squamous cell carcinoma of the penis successfully treated with imiquimod 5% cream in a porphyria cutanea tarda patient: Fernández-Crehuet et al by Fernández-Crehuet, Pablo, Ruiz-Villaverde, Ricardo, Rios-Martin, Juan J, Pérez-Gil, Amalia, Camacho-Martinez, Francisco

Get full text

Primary cutaneous anaplastic large cell lymphoma (pcALCL): Initial approach and long-term follow-up in 108 patients by Fernández-de-Misa, Ricardo, Hernández-Machín, Buenaventura, Combalia, Andrea, García-Muret, María del Pilar, Servitje, Octavio, Muniesa, Cristina, Gallardo, Fernando, Rujol, Ramón María, Martí, Rosa María, Ortiz-Brugués, Ariadna, Maroñas-Jiménez, Lidia, Ortiz-Romero, Pablo Luis, Blanch-Rius, Laura, Román, Concepción, Cañueto, Javier, Mar, Blanes, Bastida, Jesús, Morillo, Mercedes, Peñate, Yeray, Gala, Silvia Pérez, Molins, Marta, Lara, Pablo Espinosa, Gil, Amalia Pérez, Estrach, Teresa

Get full text

Effectiveness, survival and safety of guselkumab attending to basal characteristics in moderate-to-severe psoriatic patients: a cohort study [version 2; peer review: 2 approved] by Ruiz-Villaverde, Ricardo, Rodriguez-Fernandez-Freire, Lourdes, Armario-Hita, Jose C., Pérez-Gil, Amalia, Vasquez Chinchay, Fiorella, Galán-Gutiérrez, Manuel

“…Background: Psoriasis is a chronic inflammatory disease which can impact quality of life. In the past decade multiple biologic treatments have been released…”
Get full text